SYNCOM FORMULATIONS (INDIA)
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Profit Before Tax | ₹34 Cr | ₹27 Cr | ₹26 Cr | ₹16 Cr | ₹16 Cr |
Adjustment | ₹-3.48 Cr | ₹-6.11 Cr | ₹-7.16 Cr | ₹0.71 Cr | ₹1.14 Cr |
Changes In working Capital | ₹-28 Cr | ₹-3.26 Cr | ₹3.58 Cr | ₹1.29 Cr | ₹12 Cr |
Cash Flow after changes in Working Capital | ₹2.13 Cr | ₹17 Cr | ₹23 Cr | ₹18 Cr | ₹30 Cr |
Cash Flow from Operating Activities | ₹-5.96 Cr | ₹11 Cr | ₹16 Cr | ₹14 Cr | ₹24 Cr |
Cash Flow from Investing Activities | ₹83 Cr | ₹-45 Cr | ₹-27 Cr | ₹-18 Cr | ₹-23 Cr |
Cash Flow from Financing Activities | ₹-15 Cr | ₹35 Cr | ₹8.29 Cr | ₹4.67 Cr | ₹-2.41 Cr |
Net Cash Inflow / Outflow | ₹63 Cr | ₹0.58 Cr | ₹-2.45 Cr | ₹0.83 Cr | ₹-1.08 Cr |
Opening Cash & Cash Equivalents | ₹0.88 Cr | ₹0.30 Cr | ₹2.75 Cr | ₹5.69 Cr | ₹6.77 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹63 Cr | ₹0.88 Cr | ₹0.30 Cr | ₹6.52 Cr | ₹5.69 Cr |
Compare Cashflow Statement of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,706.1 Cr | -1.3% | -5.7% | 18.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -1.3% |
-5.7% |
18.4% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses